- £450,000+ in annual energy cost savings
- 3,161 tonnes of CO₂ emissions avoided per year
- 1.6MW CHP system now supplies 25% of site electricity
- Capital payback achieved in under 3.5 years
Case study
Project overview
Faced with rising energy costs and a projected doubling of their £4 million annual utility spend, a global pharmaceutical manufacturer sought a solution that would deliver measurable savings and long-term value. Projective was engaged to identify a tailored, high-impact solution with a payback period of less than four years.
Key Actions:
CHP systems often suffer from inefficiencies due to poor sizing and integration. By modelling the site’s full thermal profile, Projective engineered a solution that maximised efficiency and minimised capital expenditure.
The CHP system was designed to superheat boiler feed water in two stages, first using engine cooling energy, then exhaust heat, raising temperatures to 150°C and significantly reducing gas usage.
This tailored solution now generates 25% of the site’s electricity demand, improving operational resilience and reducing environmental impact.
Smart, efficient CHP design
Lower emissions
Robust, high-performance delivery
The installed system now delivers 1.6MW of electrical power, saving over £450,000 annually and reducing carbon emissions by more than 3,161 tonnes per year.
With a capital payback achieved in under 3.5 years, the project demonstrates how strategic engineering can unlock sustainable performance improvements.
Outcomes:
This project reflects how Projective works as a strategic partner, not just delivering technical solutions, but helping clients achieve long-term operational and sustainability goals.
Key success factors:
By combining deep technical expertise with a client-focused mindset, Projective helped a global pharmaceutical manufacturer future-proof their energy strategy and unlock measurable value. It’s a partnership built on trust, transparency and results.
Learn more about this case study and download it as a PDF file with more details.